Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Uplift of tariff prices for 2022/23 National Tariff Payment System in England

In late May 2022, NHS England and NHS Improvement recalculated tariff prices to reflect higher inflation levels. They published an updated version of the 2022/23 national tariff workbook (Annex A) and the non-mandatory prices workbook. The increased prices should be used wherever tariff prices apply.

The cost uplift factor that should be used for the 2022/23 tariff has increased to 3.5%, from the 2.8% in the initially published tariff. The increased cost uplift figure should be used for local pricing arrangements (including aligned payment and incentive agreements).

See the more details here

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).